RxDoctor Payments DataLook up a doctor →

Claudia Chiriboga

Neurology with Special Qualifications in Child Neurology · New York, NYNPI 1972537967

Payments from drug & device makers

$8,493,274in general payments, 2019–2025

Across 464 payments — averaging $18,304 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$5.5M
  • Hoffmann-la Roche Limited$1.6M
  • Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$575K
  • Genentech, Inc.$340K
  • F. Hoffmann-la Roche AG$280K
  • Genentech USA, Inc.$50K
  • plus $112K from 7 others
$19,017in research payments, 2019–2025

Across 43 payments — averaging $442.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$19K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,493,274 in reported general payments places this provider in the 95th percentile of 161 neurology with special qualifications in child neurology providers in New York.

See all neurology with special qualifications in child neurology providers in New York

Other neurology with special qualifications in child neurology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →